Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Seven Bridges has been selected by the PanCAN to build a customized, integrated health data platform to accelerate pancreatic cancer research.
read more
Sygnature Discovery is supporting Professor Sachin Gupte, a pharmacologist at the New York Medical College, in his endeavors to find a drug treatment for the lung damage that can result from COVID-19 infection.
read more
YPrime announced the release of its fourth-generation eCOA platform, which is designed to promote data integrity, accuracy and completeness through a feature-rich user experience, domain expertise support and data visibility for sponsors.
read more
Octapharma and BioMatrix Specialty Pharmacy are supporting a new study focused on treating patients with COVID-19 and presenting with COVID-19-associated myocardial dysfunction.
read more
The companies are coming together to form a coalition to accomplish their shared goal of bringing promising cancer therapies to patients.
read more
Boehringer Ingelheim and Eli Lilly announced a research collaboration with DCRI for the prevention of Chronic heart failure and mortality after an acute Myocardial Infarction.
read more
Chi-Med and BeiGene have entered into a collaboration agreement to evaluate two of Chi-Med’s drug candidates, surufatinib and fruquintinib, with BeiGene’s anti-PD-1 antibody tislelizumab, for solid tumor cancers.
read more
Rho is coordinating a new study to help determine the rate of the new coronavirus infection in children and their family members in the U.S.
read more
Airway Therapeutics and Celonic Group announced a collaboration to produce the novel human recombinant protein AT-100 as a therapeutic candidate against COVID-19.
read more
The ICDD and the CCDC have announced a new partnership, which will allow greater utility and insights in the development of new drugs and materials.
read more
Humanigen has dosed the first COVID-19 patient in its study for lenzilumab, the company’s GM-CSF monoclonal antibody.
read more
Panthera is now undertaking Phase II, III and IV vaccine trials on behalf of its pharma and CRO clients across its growing network of sites in the UK.
read more
ReiThera, Leukocare, and Univercells announced a collaboration for the development and largescale manufacturing of a novel adenoviral vector-based vaccine against COVID-19.
read more
Inato has released its anticovid platform, a comprehensive, central repository for all existing clinical trials for SARS-CoV 2.
read more
Wednesday, April 15, 2020
Horizon Discovery announced special commercial licensing terms to facilitate rapid access to its cGMP-compliant CHOSOURCE™ platform for the development or production of therapeutic proteins, diagnostic assay components or vaccines relating to COVID-...
read more